Review of Ongoing Trial on Olaparib With or Without Atezolizumab in Patients with HER2- BRCAmt Breast Cancer - From Bench to Bedside & Back
By
Yale Cancer Center
FEATURING
Patricia LoRusso
By
Yale Cancer Center
FEATURING
Patricia LoRusso
Login to view comments.
Click here to Login